Synchronous primary carcinomas of the bladder and prostate.

Sheng-hui Lee; Phei-lang Chang; Shao-ming Chen; Guang-huan Sun; Chien-lun Chen; Biing-yir Shen; Ya-shen WU; Ke-hung Tsui

Return

Synchronous primary carcinomas of the bladder and prostate.

Author: Sheng-Hui LEE ¹ ; Phei-Lang CHANG ; Shao-Ming CHEN ; Guang-Huan SUN ; Chien-Lun CHEN ; Biing-Yir SHEN ; Ya-Shen WU ; Ke-Hung TSUI
Author Information

1. Division of Geriatric Urology, Department of Surgery, Chang Gung Memorial Hospital, School of Medicine, Chang Gung University, 5 Fu-Shin Street, Kweishan, Taoyuan 333, Taiwan, China.
Publication Type:Journal Article
MeSH: Carcinoma, Transitional Cell; pathology; surgery; Humans; Male; Neoplasm Staging; Prostatectomy; Prostatic Neoplasms; complications; surgery; Urinary Bladder Neoplasms; complications; pathology; surgery
From: Asian Journal of Andrology 2006;8(3):357-359
CountryChina
Language:English
Abstract:
AIMTo determine the incidence of adenocarcinoma of the prostate for patients undergoing radical cystoprostatectomy for bladder cancer in Taiwan.
METHODSA total of 248 patients in Taiwan who were histologically confirmed for transitional cell carcinoma of the bladder underwent cystoprostatectomy. Histopathologic evaluation of the prostate specimens sectioned at 5 mm intervals was performed.
RESULTSOf the 248 patients, 10 (4.03%) were found to have prostate cancer. Of the 10 cases of unsuspected prostate cancer, eight proved to be at stage T1 or T2, and two at T3 and T4, respectively. This rate of incidentally found prostate cancer amongst our bladder cancer patients appeared to be lower than that found in bladder cancer patients in similar studies in USA.
CONCLUSIONAlthough the incidence of incidental prostate cancer in patients in Taiwan with bladder cancer is not high compared with that in Western countries, we suggest that digital rectal examination and prostate-specific antigen (PSA) are important screening tools for men with bladder cancer, especially for those aged 60 years and older in Taiwan.